Barcelona, May 29, 2020.- VHIO researchers have taken part in important new studies on colorectal cancer that could improve clinical…
Barcelona, May 29, 2020.- VHIO researchers have presented research on cancer treatments and the dangers of burnout among oncologists at…
Barcelona, May 29, 2020.- The VHIO is presenting a series of new breast cancer treatments at one of the year’s…
Barcelona, May 29, 2020.- The first steps are being taken to validate a test to accurately select the right cancer…
Vall d’Hebron Hospital has taken a very active part in the COMBAT multicenter study recruiting patients with advanced pancreatic cancer…
Barcelona, May 07, 2020.- Researchers are close to bringing a new cancer treatment that inhibits the oncoprotein Myc to the…
Clinical trial results for olaparib, already used to treat ovary and breast cancer, support the first personalized prostate cancer treatment…
The current COVID-19 pandemic has forced us to review our protocols and the way we care for cancer patients, as…
Barcelona, April 8, 2020.- A Vall d’Hebron Institute of Oncology (VHIO) project to help fight the COVID-19 virus is to…
Barcelona, March 18, 2020.- A project from the Vall d’Hebron Institute of Oncology (VHIO) is among the four selected in…
The Neuroendocrine Tumors Unit has passed the strict European Neuroendocrine Tumor Society (ENETS) audit Because these are very complex cases,…
Building on the successes of the two previous VHIO-“la Caixa” Institutional 3-year Programs, we are delighted to announce that this…
